Benefit Plans (Tables)

6 Months Ended

Apr. 30, 2024

Benefit Plans

Schedule of Share-Based Compensation Reflected in Consolidated Statement of Operations and Comprehensive Loss

Share-based compensation was reflected in the Consolidated Statements of Operations and Comprehensive Loss as follows (in thousands):

	Three Months Ended April 30,				Six Months Ended April 30,
	2024		2023		2024		2023
Cost of revenues	$	339	$	413	$	736	$	747
Administrative and selling expense		2,148		2,320		4,195		4,262
Research and development expense		417		363		778		659
	$	2,904	$	3,096	$	5,709	$	5,668

Summary of RSU Activity

The following table summarizes our RSU activity for the six months ended April 30, 2024:

Restricted Stock Units	Shares	Weighted-Average Fair Value
Outstanding as of October 31, 2023	6,543,138	$	5.06
Granted - time-vesting RSUs(1)	4,893,269		1.32
Vested	(1,990,154)		7.22
Forfeited	(49,198)		3.51
Outstanding as of January 31, 2024	9,397,055	$	2.67
Granted - time-vesting RSUs	4,583,758		1.14
Granted - PSUs	3,274,384		1.63
Vested	(129,820)		5.13
Forfeited	(63,279)		3.05
Outstanding as of April 30, 2024	17,062,098	$	2.17

(1) This total includes only time-vesting RSUs and does not include the RSUs and PSUs that were contingent upon stockholder approval, as discussed above. Such shares are shown as granted during the three months ended April 30, 2024.